pyridostigmine
CAS No. 155-97-5
pyridostigmine( Pyridostigminum,Regonol,Mestinon-SR )
Catalog No. M22264 CAS No. 155-97-5
Pyridostigmine is an acetylcholinesterase inhibitor that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 162 | In Stock |
|
| 5MG | 170 | In Stock |
|
| 10MG | 258 | In Stock |
|
| 25MG | 426 | In Stock |
|
| 50MG | 586 | In Stock |
|
| 100MG | 792 | In Stock |
|
| 200MG | 1051 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namepyridostigmine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPyridostigmine is an acetylcholinesterase inhibitor that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.
-
DescriptionPyridostigmine is an acetylcholinesterase inhibitor that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.Pyridostigmine holds promise for the treatment of various gastrointestinal symptoms in SSc patients, particularly in patients with refractory constipation. Though side effects may limit its use, most patients who experienced benefit chose to continue therapy.
-
In Vitro——
-
In Vivo——
-
SynonymsPyridostigminum,Regonol,Mestinon-SR
-
PathwayOthers
-
TargetOther Targets
-
Recptoracetylcholinesterase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number155-97-5
-
Formula Weight261.12
-
Molecular FormulaC9H13BrN2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(C)C(=O)Oc1ccc[n+](C)c1.[Br-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ahuja N K , Mische L , Clarke J O , et al. Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis[J]. Semin Arthritis Rheum, 2018:S0049017217305498.
molnova catalog
related products
-
Triphenylene
Triphenylene is a compound that fluoresces in the ultraviolet region
-
BMS-593214
BMS-593214 is an active site-directed factor (F) VIIa inhibitor that exhibits antithrombotic and antihaemostatic properties.
-
2-Methylbenzhydrol
Used as pharmaceutical intermediates.
Cart
sales@molnova.com